2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
62
Phase 1
41
Phase 3
10
Phase 1/2
9
Phase EARLY_PHASE1
3
Phase 4
3
Phase 2/3
3
Phase NA
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
2
Conditions
Neoplasms
2
Interventions
Exercise
439
Blood Specimen Collection
333
Standard of Care
321
Magnetic Resonance Spectroscopy
259
Radiotherapy
255
Surveys and Questionnaires
245
Radiosurgery
245
Educational Status
230
Methods
229
Early Intervention, Educational
218
Practice Guidelines as Topic
146
Interviews as Topic
146
Biopsy
146
Surgical Procedures, Operative
135
Drug Therapy
133
Control Groups
128
Acupuncture Therapy
124
Therapeutics
110
Cyclophosphamide
103
Palliative Care
101
Counseling
101
Resistance Training
95
Saline Solution
90
Cisplatin
90
Magnetic Resonance Imaging
89
Radiofrequency Ablation
86
Specimen Handling
79
Radiotherapy, Intensity-Modulated
79
Colonoscopy
79
Cognitive Behavioral Therapy
72
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Vemurafenib
×
Clear all
NCT04801966
2023-05-10
TAILOR
Peter MacCallum Cancer Centre, Australia
Phase NA
Terminated
3 enrolled
NCT01636908
2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA
Completed
43 enrolled